Global Information
회사소개 | 문의 | 비교리스트

세계의 바이오칩 시장 예측

Global Biochips Market Forecast 2019-2028

리서치사 Inkwood Research
발행일 2020년 05월 상품 코드 603658
페이지 정보 영문 325 Pages
가격
US $ 2,500 ₩ 3,006,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,607,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,411,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 바이오칩 시장 예측 Global Biochips Market Forecast 2019-2028
발행일 : 2020년 05월 페이지 정보 : 영문 325 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 바이오칩(Biochips) 시장은 2019-2028년 13.41%의 CAGR로 추이할 것으로 예측됩니다. 바이오칩은 환자의 개요를 작성하기 위해 하나의 샘플에서 관련 검사의 패널을 동시에 분석시 사용되는 마이크로칩입니다. 이 환자의 개요는 진단, 질환 스크리닝, 질환의 진행 정도 모니터링 또는 치료 모니터링에 사용됩니다. 바이오칩은 분자진단학에서 중요한 역할을 담당하고 있으며, POC 진단에 대한 응용은 맞춤형 의료의 개발을 촉진할 것으로 기대되고 있습니다. 맞춤형 의료를 기반으로 한 분석에 대한 중점화가 바이오칩 시장의 성장을 지원하고 있습니다. 맞춤형 의료는 환자에게 조기진단을 촉구하고, 최적의 치료 및 리스크 평가 등 저비용으로 개선된 의료를 제공합니다.

세계의 바이오칩 시장을 조사했으며, 시장의 개요, 유형·기재·최종사용자·지역별 시장 규모의 추이와 예측, 시장 성장요인 및 저해요인 분석, 시장 기회, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 범위와 조사 방법

  • 조사 목적
  • 조사 범위
  • 조사 방법
  • 전제와 제한

제2장 개요

  • 시장 규모와 예측
  • 시장 개요

제3장 시장 역학

  • 시장의 정의
  • 성장요인
    • 만성질환의 이환율 상승
    • 맞춤형 의료에 대한 관심의 증가
    • 암연구에서 프로테오믹스와 게노믹스의 응용
    • POC 진단의 급속한 확대
  • 저해요인
    • 높은 계측 비용
    • 바이오칩 기술에 관한 일반인의 인식 부족
    • 대체 기술 : 차세대 시퀀싱(NGS) 기술
    • 생물학적 시스템의 복잡성
    • 일반적인 규제 기준의 결여

제4장 시장 분석

  • 신종 코로나바이러스 감염증(COVID-19)의 시장에 대한 영향
  • 주요 투자 인사이트
  • Porter의 산업 분석
    • 구매자의 교섭력
    • 공급 기업의 교섭력
    • 신규 진출업체의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계
  • 기회 매트릭스
  • 벤더 구도
  • 주요 구매 기준
  • 규제 프레임워크

제5장 세계의 바이오칩 시장 : 유형별

  • DNA 칩
  • 랩온어칩
  • 프로테인 칩
  • 기타

제6장 세계의 바이오칩 시장 : 기재별

  • 유리
  • 폴리머
  • 실리콘
  • 기타

제7장 세계의 바이오칩 시장 : 최종사용자별

  • 제약·바이오테크놀러지 기업
  • 병원·진단 센터
  • 학술연구기관

제8장 세계의 바이오칩 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 러시아
    • 벨기에
    • 폴란드
    • 기타
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 태국
    • 인도네시아
    • 베트남
    • 호주·뉴질랜드
    • 기타
  • 기타 지역
    • 라틴아메리카
    • 중동·아프리카

제9장 기업 개요

  • ABBOTT LABORATORIES INC
  • AGILENT TECHNOLOGIES INC
  • BIOCHAIN INSTITUTE INC
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC
  • CEPHEID
  • CYBRDI INC
  • F HOFFMANN-LA ROCHE LTD
  • FLUIDIGM CORPORATION
  • GE HEALTHCARE
  • ILLUMINA INC
  • MERCK KGAA
  • PERKINELMER INC
  • RANDOX LABORATORIES LTD
  • THERMO FISHER SCIENTIFIC INC
KSA 20.05.28

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - BIOCHIPS
  • TABLE 2: ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN 2018
  • TABLE 3: REGULATORY FRAMEWORK
  • TABLE 4: GLOBAL BIOCHIPS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL BIOCHIPS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL AGRICULTURAL BIOTECHNOLOGY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL CANCER DIAGNOSIS & TREATMENT MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL GENE EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL GENE EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL OTHER DNA CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL GENOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL GENOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: GLOBAL POINT OF CARE & IN VITRO DIAGNOSIS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: GLOBAL OTHER LAB ON A CHIP MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: GLOBAL PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 43: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 45: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 46: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 47: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 48: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 49: GLOBAL EXPRESSION PROFILING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 50: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 51: GLOBAL HIGH THROUGHPUT SCREENING MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 52: GLOBAL PROTEOMICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 53: GLOBAL PROTEOMICS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 54: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 55: GLOBAL OTHER PROTEIN CHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 56: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 57: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 58: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 59: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 60: GLOBAL CELL ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 61: GLOBAL CELL ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 62: GLOBAL TISSUE ARRAYS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 63: GLOBAL TISSUE ARRAYS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 64: PROPERTIES OF BIOCHIPS SUBSTRATE MATERIALS
  • TABLE 65: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 66: GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIALS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 67: GLOBAL GLASS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 68: GLOBAL GLASS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 69: GLOBAL POLYMERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 70: GLOBAL POLYMERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 71: GLOBAL SILICON MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 72: GLOBAL SILICON MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 73: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 74: GLOBAL OTHER SUBSTRATE MATERIALS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 75: GLOBAL BIOCHIPS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 76: GLOBAL BIOCHIPS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 77: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 78: GLOBAL BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 79: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 80: GLOBAL HOSPITALS AND DIAGNOSTICS CENTERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 81: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 82: GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 83: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 84: GLOBAL BIOCHIPS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 85: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 86: NORTH AMERICA BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 87: EUROPE BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 88: EUROPE BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 89: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 90: ASIA PACIFIC BIOCHIPS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 91: REST OF WORLD BIOCHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 92: REST OF WORLD BIOCHIPS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: DEVELOPMENT OF BIOCHIPS
  • FIGURE 2: KEY INVESTMENT INSIGHTS
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: KEY BUYING CRITERIA
  • FIGURE 8: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2019
  • FIGURE 9: GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY DNA CHIPS, IN 2019
  • FIGURE 11: GLOBAL BIOCHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL BIOCHIPS MARKET, BY CANCER DIAGNOSIS & TREATMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL BIOCHIPS MARKET, BY GENE EXPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL BIOCHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL BIOCHIPS MARKET, BY OTHER DNA CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY LAB ON A CHIP, IN 2019
  • FIGURE 20: GLOBAL BIOCHIPS MARKET, BY CLINICAL DIAGNOSTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL BIOCHIPS MARKET, BY GENOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL BIOCHIPS MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL BIOCHIPS MARKET, BY OTHER LAB ON A CHIP, 2019-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY PROTEIN CHIPS, IN 2019
  • FIGURE 28: GLOBAL BIOCHIPS MARKET, BY DIAGNOSTICS, 2019-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL BIOCHIPS MARKET, BY DRUG DISCOVERY, 2019-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL BIOCHIPS MARKET, BY EXPRESSION PROFILING, 2019-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL BIOCHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL BIOCHIPS MARKET, BY PROTEOMICS, 2019-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL BIOCHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2028 (IN $ MILLION)
  • FIGURE 34: GLOBAL BIOCHIPS MARKET, BY OTHER TYPES, 2019-2028 (IN $ MILLION)
  • FIGURE 35: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY OTHER TYPES, IN 2019
  • FIGURE 36: GLOBAL BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2028 (IN $ MILLION)
  • FIGURE 37: GLOBAL BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2028 (IN $ MILLION)
  • FIGURE 38: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY SUBSTRATE MATERIALS, IN 2019
  • FIGURE 39: GLOBAL BIOCHIPS MARKET, BY GLASS, 2019-2028 (IN $ MILLION)
  • FIGURE 40: GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2019-2028 (IN $ MILLION)
  • FIGURE 41: GLOBAL BIOCHIPS MARKET, BY SILICON, 2019-2028 (IN $ MILLION)
  • FIGURE 42: GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2028 (IN $ MILLION)
  • FIGURE 43: GLOBAL BIOCHIPS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 44: GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2028 (IN $ MILLION)
  • FIGURE 45: GLOBAL BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2028 (IN $ MILLION)
  • FIGURE 46: GLOBAL BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
  • FIGURE 47: NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 48: UNITED STATES BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 49: CANADA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 50: EUROPE BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 51: UNITED KINGDOM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 52: GERMANY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 53: FRANCE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 54: ITALY BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 55: RUSSIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 56: BELGIUM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 57: POLAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 58: REST OF EUROPE BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 59: ASIA PACIFIC BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 60: CHINA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 61: JAPAN BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 62: INDIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 63: SOUTH KOREA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 64: INDONESIA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 65: THAILAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 66: VIETNAM BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 67: AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 68: REST OF ASIA PACIFIC BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 69: REST OF WORLD BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 70: LATIN AMERICA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 71: MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2028 (IN $ MILLION)

KEY FINDINGS

The global biochips market is projected to register a CAGR of 13.41% during the forecast period of 2019-2028. Increasing incidences of chronic diseases, rising investments in medical and healthcare research, growth in personalized medicine, developing software and service sectors in proteomics and genomics, and rapidly growing use of point-of-care testing diagnosis are the principal factors contributing to the global market growth.

MARKET INSIGHTS

Biochip is a microchip used to simultaneously analyze a panel of related tests in a single sample producing a patient's profile. The patient profile can be used in diagnosis, disease screening, monitoring disease progression, or monitoring treatment. Biochips play an important role in molecular diagnostics, and their application in point-of-care diagnosis is expected to facilitate the development of personalized medicines. Emphasis on personalized medicine-based analytics is adding growth to the biochips market. Personalized medicines offer patients an early diagnosis, optimal treatments, risk assessments, low-cost improved healthcare. The success of personalized medicine depends upon information and record of reliable and accurate diagnostics.

The complexity of biological systems is a major challenge for the biochips market. The large-scale testing on a single chip creates complexity. Lab on a chip in the type segment collected the largest revenue share in 2019. Biotechnology and pharmaceutical companies are the fastest-growing end-users. There is a sustainable competitive advantage through innovations between companies in the market.

REGIONAL INSIGHTS

The global biochips market is surveyed geographically by segmenting into regions of Europe, Asia Pacific, North America, and the Rest of the World. The region of North America dominated the market in 2019 in terms of revenue, due to growing awareness about biochips and their widespread applications in various fields such as personalized medicine, clinical diseases, agri-genomics, and others.

COMPETITIVE INSIGHTS

The biochips market is highly competitive, dominated by well-established companies, and also multiple new players holding the majority of market share. Some of the participants competing in the market are Abbott Laboratories Inc, F. Hoffmann-La Roche Ltd, Randox Laboratories Ltd, GE Healthcare, Merck KGaA, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation cater to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS: GENOMICS AND PROTEOMICS MARKET
  • 3.2. DEVELOPMENT OF BIOCHIPS
  • 3.3. MARKET DEFINITION
  • 3.4. KEY DRIVERS
    • 3.4.1. RISING INCIDENCES OF CHRONIC DISEASES
    • 3.4.2. GROWING INTEREST IN PERSONALIZED MEDICINES
    • 3.4.3. APPLICATION OF PROTEOMICS AND GENOMICS IN CANCER RESEARCH
    • 3.4.4. RAPIDLY GROWING USE OF POINT-OF-CARE TESTING DIAGNOSTICS
  • 3.5. KEY RESTRAINTS
    • 3.5.1. HIGH INSTRUMENTATION COST
    • 3.5.2. LACK OF AWARENESS AMONG COMMON PEOPLE ABOUT BIOCHIP TECHNOLOGY
    • 3.5.3. AVAILABILITY OF ALTERNATIVE TECHNOLOGY: NEXT GENERATION SEQUENCING (NGS) TECHNOLOGY
    • 3.5.4. COMPLEXITY OF BIOLOGICAL SYSTEMS
    • 3.5.5. LACK OF COMMON REGULATORY STANDARDS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON BIOCHIPS
  • 4.2. KEY INVESTMENT INSIGHTS
  • 4.3. PORTER'S FIVE FORCE ANALYSIS
    • 4.3.1. BUYER POWER
    • 4.3.2. SUPPLIER POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE
  • 4.6. VALUE CHAIN ANALYSIS
    • 4.6.1. RESEARCH & DEVELOPMENT
    • 4.6.2. RAW MATERIALS
    • 4.6.3. MANUFACTURING
    • 4.6.4. WHOLESALERS/RETAILERS/DISTRIBUTORS
    • 4.6.5. END-USER
  • 4.7. KEY BUYING CRITERIA
    • 4.7.1. COST
    • 4.7.2. APPLICATIONS
    • 4.7.3. PRODUCT TYPE
  • 4.8. REGULATORY FRAMEWORK

5. MARKET BY TYPE

  • 5.1. DNA CHIPS
    • 5.1.1. AGRICULTURAL BIOTECHNOLOGY
    • 5.1.2. CANCER DIAGNOSIS & TREATMENT
    • 5.1.3. DRUG DISCOVERY
    • 5.1.4. GENE EXPRESSION
    • 5.1.5. GENOMICS
    • 5.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
    • 5.1.7. OTHER DNA CHIPS
  • 5.2. LAB ON A CHIP
    • 5.2.1. CLINICAL DIAGNOSTICS
    • 5.2.2. DRUG DISCOVERY
    • 5.2.3. GENOMICS
    • 5.2.4. POINT OF CARE & IN VITRO DIAGNOSIS
    • 5.2.5. PROTEOMICS
    • 5.2.6. OTHER LAB ON A CHIP
  • 5.3. PROTEIN CHIPS
    • 5.3.1. DIAGNOSTICS
    • 5.3.2. DRUG DISCOVERY
    • 5.3.3. EXPRESSION PROFILING
    • 5.3.4. HIGH THROUGHPUT SCREENING
    • 5.3.5. PROTEOMICS
    • 5.3.6. OTHER PROTEIN CHIPS
  • 5.4. OTHER TYPES
    • 5.4.1. CELL ARRAYS
    • 5.4.2. TISSUE ARRAYS

6. MARKET BY SUBSTRATE MATERIALS

  • 6.1. GLASS
  • 6.2. POLYMERS
  • 6.3. SILICON
  • 6.4. OTHER SUBSTRATE MATERIALS

7. MARKET BY END-USER

  • 7.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
  • 7.2. HOSPITALS AND DIAGNOSTICS CENTERS
  • 7.3. ACADEMIC AND RESEARCH INSTITUTES

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. UNITED KINGDOM
    • 8.2.2. GERMANY
    • 8.2.3. FRANCE
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. CHINA
    • 8.3.2. JAPAN
    • 8.3.3. INDIA
    • 8.3.4. SOUTH KOREA
    • 8.3.5. INDONESIA
    • 8.3.6. THAILAND
    • 8.3.7. VIETNAM
    • 8.3.8. AUSTRALIA & NEW ZEALAND
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES INC
  • 9.2. AGILENT TECHNOLOGIES INC
  • 9.3. BIOCHAIN INSTITUTE INC
  • 9.4. BIOMERIEUX SA
  • 9.5. BIO-RAD LABORATORIES INC
  • 9.6. CEPHEID
  • 9.7. CYBRDI INC
  • 9.8. F HOFFMANN-LA ROCHE LTD
  • 9.9. FLUIDIGM CORPORATION
  • 9.10. GE HEALTHCARE
  • 9.11. ILLUMINA INC
  • 9.12. MERCK KGAA
  • 9.13. PERKINELMER INC
  • 9.14. RANDOX LABORATORIES LTD
  • 9.15. THERMO FISHER SCIENTIFIC INC
Back to Top
전화 문의
F A Q